Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gauri Sabnis

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Cancer|December 12, 2007
Preclinical modeling of endocrine response and resistance: focus on aromatase inhibitorsLuciana F Macedo, Gauri Sabnis, Angela Brodie
Future Oncology (London, England)|February 25, 2014
mTOR inhibitors: changing landscape of endocrine-resistant breast cancerSaranya Chumsri, Gauri Sabnis, Katherine Tkaczuk, et al.
Hormone Molecular Biology and Clinical Investigation|April 23, 2013
Upregulation of AIB1, aromatase and ERα provides long-term estrogen-deprived human breast cancer cells with a mechanistic growth advantage for survivalSyreeta L Tilghman, Gauri Sabnis, Angela M H Brodie
Hormone Molecular Biology and Clinical Investigation|May 12, 2015
Upregulation of AIB1, aromatase and ERα provides long-term estrogen-deprived human breast cancer cells with a mechanistic growth advantage for survivalSyreeta L Tilghman, Gauri Sabnis, Angela M H Brodie
Clinical Endocrinology|December 8, 2004
Prepubertal gynaecomastia caused by medication or the aromatase excess syndromeConstantine A Stratakis, Dalia Batista, Gauri Sabnis, et al.
Molecular Cancer Therapeutics|January 8, 2010
Sensitivity to the aromatase inhibitor letrozole is prolonged after a "break" in treatmentGauri Sabnis, Olga Goloubeva, Rabia Gilani, et al.
Molecular Cancer Therapeutics|June 4, 2015
Histone Deacetylase Inhibitor Entinostat Inhibits Tumor-Initiating Cells in Triple-Negative Breast Cancer CellsAmanda Schech, Armina Kazi, Stephen Yu, et al.
Endocrine-Related Cancer|June 27, 2015
A nude mouse model of obesity to study the mechanisms of resistance to aromatase inhibitorsAmanda Schech, Stephen Yu, Olga Goloubeva, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2007
Inhibition of the phosphatidylinositol 3-kinase/Akt pathway improves response of long-term estrogen-deprived breast cancer xenografts to antiestrogensGauri Sabnis, Olga Goloubeva, Danijela Jelovac, et al.
The Journal of Steroid Biochemistry and Molecular Biology|February 22, 2011
Aromatase, aromatase inhibitors, and breast cancerSaranya Chumsri, Timothy Howes, Ting Bao, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Cancer|December 12, 2007
Preclinical modeling of endocrine response and resistance: focus on aromatase inhibitorsLuciana F Macedo, Gauri Sabnis, Angela Brodie
Future Oncology (London, England)|February 25, 2014
mTOR inhibitors: changing landscape of endocrine-resistant breast cancerSaranya Chumsri, Gauri Sabnis, Katherine Tkaczuk, et al.
Hormone Molecular Biology and Clinical Investigation|April 23, 2013
Upregulation of AIB1, aromatase and ERα provides long-term estrogen-deprived human breast cancer cells with a mechanistic growth advantage for survivalSyreeta L Tilghman, Gauri Sabnis, Angela M H Brodie
Hormone Molecular Biology and Clinical Investigation|May 12, 2015
Upregulation of AIB1, aromatase and ERα provides long-term estrogen-deprived human breast cancer cells with a mechanistic growth advantage for survivalSyreeta L Tilghman, Gauri Sabnis, Angela M H Brodie
Clinical Endocrinology|December 8, 2004
Prepubertal gynaecomastia caused by medication or the aromatase excess syndromeConstantine A Stratakis, Dalia Batista, Gauri Sabnis, et al.
Molecular Cancer Therapeutics|January 8, 2010
Sensitivity to the aromatase inhibitor letrozole is prolonged after a "break" in treatmentGauri Sabnis, Olga Goloubeva, Rabia Gilani, et al.
Molecular Cancer Therapeutics|June 4, 2015
Histone Deacetylase Inhibitor Entinostat Inhibits Tumor-Initiating Cells in Triple-Negative Breast Cancer CellsAmanda Schech, Armina Kazi, Stephen Yu, et al.
Endocrine-Related Cancer|June 27, 2015
A nude mouse model of obesity to study the mechanisms of resistance to aromatase inhibitorsAmanda Schech, Stephen Yu, Olga Goloubeva, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2007
Inhibition of the phosphatidylinositol 3-kinase/Akt pathway improves response of long-term estrogen-deprived breast cancer xenografts to antiestrogensGauri Sabnis, Olga Goloubeva, Danijela Jelovac, et al.
The Journal of Steroid Biochemistry and Molecular Biology|February 22, 2011
Aromatase, aromatase inhibitors, and breast cancerSaranya Chumsri, Timothy Howes, Ting Bao, et al.
Pageof 4